Latest Ratings from Top Wall Street Institutions: Palantir Upgraded, Workday Downgraded
Five Major Rating Upgrades
- Mizuho upgraded Palantir (PLTR) from Neutral to Outperform, with the target price unchanged at $195. The firm noted the company's total revenue growth, accelerating momentum, and margin expansion, stating that “Palantir's scale performance is unique in the software industry.”
- Rosenblatt upgraded Cadence Design Systems (CDNS) from Neutral to Buy and raised the target price from $335 to $360. The firm believes the company's fourth quarter results were “comprehensively robust.”
- Baird upgraded Itron (ITRI) from Neutral to Outperform, raising the target price from $118 to $128, and recommended buying after the fourth-quarter earnings report.
- Citizens upgraded Rush Street Interactive (RSI) from Market Perform to Outperform, with a target price of $24. The firm stated the company “continues to prove it has built one of the most resilient business models in the online gaming space.”
- TD Cowen upgraded Medpace (MEDP) from Sell to Hold, lowering the target price from $462 to $419. The firm noted that the stock has retreated from its valuation peak and now reflects reasonable value.
Five Major Rating Downgrades
- Citizens downgraded Workday (WDAY) from Outperform to Market Perform after the company announced the return of its founder as CEO and previewed fourth-quarter results, with no target price set. The firm said that the shift from SaaS to the AI era requires internal AI innovation and the founder’s investment of time and capital.
- Williams Trading downgraded Crocs (CROX) from Hold to Sell, raising the target price from $75 to $84. The firm cited continued weakening demand in the U.S. market.
- Citizens downgraded Similarweb (SMWB) from Outperform to Market Perform, with no target price set. The company’s fourth-quarter revenue was significantly below expectations, and its guidance also fell short.
- Truist downgraded Genuine Parts (GPC) from Buy to Hold, lowering the target price from $162 to $127. While business spinoffs are theoretically positive, the automotive segment continues to disappoint.
- BTIG downgraded Masimo (MASI) from Buy to Neutral after Danaher (DHR) announced the $180 per share cash acquisition of Masimo.
Five Major Initiations/Resumptions of Coverage
- Mizuho resumed coverage of Medtronic (MDT) with an Outperform rating and a target price of $125. New products are expected to drive growth in fiscal 2027.
- Compass Point initiated coverage of Nebius (NBIS) with a Buy rating and a target price of $150. The company is a full-stack AI infrastructure provider, offering GPU computing power and an AI cloud platform.
- UBS initiated coverage of AeroVironment (AVAV) with a Neutral rating and a target price of $259. Its 2028 profit margin outlook is lower than consensus bullish expectations.
- UBS initiated coverage of Kratos Defense (KTOS) with a Neutral rating and a target price of $79. The current share price already fully reflects growth expectations.
- Roth Capital initiated coverage of Modine (MOD) with a Buy rating and a target price of $263. The company provides data centers with unique one-stop thermal management solutions for cooling and refrigeration.
Editor: Guo Mingyu
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic files for IPO: lost $4.2 billion last year, revenue grew 12x to $4.6 billion, risk section warns of "threats to human survival"
Anthropic's IPO prospectus reveals that its spending on computing power and infrastructure will reach $7.33 billion in 2025, a twofold increase from 2024, accounting for more than half of its total operating expenses of $12.65 billion. The company plans to continue investing over $500 billion in the future. The risk section of the prospectus extends to 80 pages, explicitly warning that its AI models could pose "catastrophic or even existential threats," and may even resist shutdowns or manipulate information.
Meta shocks Wall Street by hiring MongoDB CEO and makes a high-profile entry into enterprise AI business
Meta has established an enterprise AI division called "Meta Enterprise Platform," which Mark Zuckerberg described as "the next important pillar." MongoDB CEO CJ Desai has been recruited to lead it. Analysts noted that Zuckerberg specifically poached a CEO from a publicly listed company to demonstrate the importance of this move. Desai's departure was announced just one day before Investor Day, with the timing surprising the public.
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
Crypto prices
More
